Dow Down 0.62% Nasdaq Down 1.14%

Celgene Corporation (CELG)

-NasdaqGS
92.19 1.66(1.77%) Sep 22, 4:00PM EDT
Prev Close:93.85
Open:93.26
Bid:90.20 x 200
Ask:92.00 x 100
1y Target Est:102.69
Beta:1.1
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:91.37 - 93.45
52wk Range:66.85 - 96.44
Volume:3,590,044
Avg Vol (3m):4,317,760
Market Cap:73.71B
P/E (ttm):29.34
EPS (ttm):3.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGDown 1.77%73.71B
JNJ304.25B

Key Statistics

Forward P/E (1 yr):18.85
P/S (ttm):10.67
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.68
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.95

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback